TLX Stock Overview

Profile

Full Name:

Telix Pharmaceuticals Limited

Sector:

Healthcare

Industry:

Biotechnology

Country:

Australia

IPO:

November 14, 2024

Indexes:

Not included

Website:

http://telixpharma.com

Description:

TLX Corporation is a company that specializes in providing technology solutions and services, focusing on enhancing communication and connectivity for businesses and individuals.

Key Details

Price

$19.92

Market Cap

$6.67 B(Mid cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$329.72 M(+204.34% YoY)

Annual EPS

$0.01(+104.60% YoY)

PE Ratio

-

Annual ROE

4.44%

Annual Debt To Equity

0.06

Beta

0.14

Events Calendar

Earnings

Next earnings date:

Feb 21, 2025

Recent quarterly earnings:

Aug 22, 2024

Recent annual earnings:

Feb 21, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 27, 25 UBS
Buy
Nov 15, 24 UBS
Buy

Screeners with TLX included

Growing Shares Outstanding
Mid cap stocks
Stocks at all time highs
Best performing stocks last 3 months
Earnings today
Stocks above SMA 50
Stocks ready to break out
Healthcare sector
All stocks
High Altman Z score stocks

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$19.92
TLX price is $19.92

Price All-time High

$19.92
TLX price is currently at an all-time high

Price Analysts Target

-
TLX price consensus analysts' forecast is unknown

Price Most Recent Change

+14.42%
TLX price was up +14.42% on Feb 21, 2025

Price YTD Change

+29.35%
TLX price is up +29.35% since January 1st

Price 3-Year Change

-
TLX price 3-year change is unknown

Market cap

Market Cap

$6.67 B
TLX market capitalization is $6.67 billion

Market Cap 3-Year Change

-
TLX market capitalization 3-year change is unknown

Market Cap All-time High

$6.67 B
TLX market capitalization is currently at an all-time high

Market Cap Sector Rank

89.76%
TLX market capitalization is higher than 89.76% of companies in Healthcare sector

Technical

Beta

0.14
TLX beta is 0.14

200-day SMA

$16.43
TLX price is currently +21.21% above its 200-day simple moving average

14-day RSI

68.76
TLX 14-day relative strength index is 68.76

30-day Relative Volume

2.23
TLX 30-day relative volume is 2.23

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$329.72 M
TLX annual revenue is $329.72 million

Annual Revenue Analysts Estimate

$779.38 M
TLX annual revenue is currently -57.69% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+204.34%
TLX annual revenue is up +204.34% year-on-year

Annual Revenue Sector Rank

71.57%
TLX annual revenue is higher than 71.57% of companies in Healthcare sector

Profit

Annual Gross Profit

$204.81 M
TLX annual gross profit is $204.81 million

Annual Gross Margin

62.12%
TLX annual gross profit margin is 62.12%

Annual Operating Profit

$26.05 M
TLX annual operating income is $26.05 million

Annual Operating Margin

7.90%
TLX annual operating profit margin is 7.90%

Annual Net Income

$3.46 M
TLX annual net profit is $3.46 million

Annual Net Margin

1.05%
TLX annual net profit margin is 1.05%

EPS

Annual EPS

$0.01
TLX annual earnings per share is $0.01

Annual EPS Analysts Estimate

$0.19
TLX annual earnings per share is currently -94.45% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

+104.6%
TLX annual earnings per share is up +104.6% year-on-year

Annual EPS Sector Rank

83.6%
TLX annual earnings per share is higher than 83.6% of companies in Healthcare sector

ROA & ROE

Annual ROA

1.55%
TLX annual return on assets is 1.55%

Annual ROE

4.44%
TLX annual return on equity is 4.44%

EBIT & EBITDA

Annual EBIT

$10.77 M
TLX annual earnings before interest & taxes is $10.77 million

Annual EBITDA

$15.25 M
TLX annual EBITDA is $15.25 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
TLX price to earnings ratio value is unknown

PE Ratio Sector Rank

-
TLX price to earnings ratio is unknown

PB Ratio

PB Ratio

24.69
TLX price to book ratio is 24.69

PB Ratio Sector Rank

96.88%
TLX price to book ratio is higher than 96.88% of companies in Healthcare sector

PS Ratio

PS Ratio

-
TLX price to sales ratio value is unknown

PS Ratio Sector Rank

-
TLX price to sales ratio is unknown

Enterprise value

Enterprise Value

$6.60 B
TLX enterprise value is $6.60 billion

Enterprise Value Sector Rank

90.22%
TLX enterprise value is higher than 90.22% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
TLX EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
TLX EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

1.43
TLX annual current ratio is 1.43

Annual Quick Ratio

1.32
TLX annual quick ratio is 1.32

Leverage

Annual Debt To Equity

0.06
TLX annual debt to equity ratio is 0.06

Annual Interest Coverage Ratio

1.24
TLX annual interest coverage ratio is 1.24

Risk & Stability

Piotroski F-Score

-
TLX piotroski f-score value is unknown

Altman Z-Score

24.17
TLX altman z-score is 24.17

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$271.36 M
TLX annual total assets is $271.36 million

Annual Non Current Assets

$118.17 M
TLX annual long term assets is $118.17 million

Annual Current Assets

$153.19 M
TLX annual total current assets is $153.19 million

Annual Cash & Cash Equivalents

$83.96 M
TLX annual cash & cash equivalents is $83.96 million

Equity

Annual Book Value

$101.45 M
TLX annual book value is $101.45 million

Annual Working Capital

$45.95 M
TLX annual working capital is $45.95 million

Liabilities

Annual Total Liabilities

$169.91 M
TLX annual total liabilities is $169.91 million

Annual Total Long Term Liabilities

$62.67 M
TLX annual total long term liabilities is $62.67 million

Annual Current Liabilities

$107.24 M
TLX annual total current liabilities is $107.24 million

Annual Accounts Payable

$22.37 M
TLX annual accounts payable is $22.37 million

Debt

Annual Total Debt

$11.89 M
TLX annual total debt is $11.89 million

Annual Total Debt 1-Year Change

+67.25%
TLX annual total debt is up +67.25% year-on-year

Annual Long Term Debt

$10.82 M
TLX annual long term debt is $10.82 million

Annual Short Term Debt

$1.06 M
TLX annual short term debt is $1.06 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

-
TLX annual total expenses value is unknown

Annual Operating Expenses

$178.76 M
TLX annual total operating expenses is $178.76 million

Annual Cost Of Goods Sold

$124.91 M
TLX annual cost of goods sold is $124.91 million

Annual SGA

$88.86 M
TLX annual SGA is $88.86 million

Annual D&A

-
TLX annual depreciation & amortization value is unknown

Annual Interest Expense

$8.72 M
TLX annual interest expense is $8.72 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-
TLX annual cash flow from operations value is unknown

Annual CFO 1-Year Change

-
TLX annual cash flow from operations 1-year change is unknown

Annual CFI

-$16.92 M
TLX annual cash flow from investing activities is -$16.92 million

Annual CFI 1-Year Change

-43.34%
TLX annual cash flow from investing activities is down -43.34% year-on-year

Annual CFF

$6.76 M
TLX annual cash flow from financing activities is $6.76 million

Annual CFF 1-Year Change

-94.44%
TLX annual cash flow from financing activities is down -94.44% year-on-year

Free CashFlow

Annual FCF

-
TLX annual free cash flow value is unknown

Annual FCF 1-Year Change

-
TLX annual free cash flow 1-year change is unknown

CAPEX

Annual CAPEX

$7.17 M
TLX annual capital expenditures is $7.17 million

Annual CAPEX 1-Year Change

-25.57%
TLX annual capital expenditures is down -25.57% year-on-year

Institutional Ownership

Similar stocks

AXSM logo
Axsome Therapeutics (AXSM)
BBIO logo
BridgeBio Pharma (BBIO)
GKOS logo
Glaukos (GKOS)
RVMD logo
Revolution Medicines (RVMD)
CORT logo
Corcept Therapeutics Incorporated (CORT)
HALO logo
Halozyme Therapeutics (HALO)
LEGN logo
Legend Biotech (LEGN)
ENSG logo
Ensign (ENSG)
MDGL logo
Madrigal Pharmaceuticals (MDGL)

FAQ

  • What is the ticker symbol for Telix Pharmaceuticals Limited?
  • Does Telix Pharmaceuticals Limited pay dividends?
  • What sector is Telix Pharmaceuticals Limited in?
  • What industry is Telix Pharmaceuticals Limited in?
  • What country is Telix Pharmaceuticals Limited based in?
  • When did Telix Pharmaceuticals Limited go public?
  • Is Telix Pharmaceuticals Limited in the S&P 500?
  • Is Telix Pharmaceuticals Limited in the NASDAQ 100?
  • Is Telix Pharmaceuticals Limited in the Dow Jones?
  • When was Telix Pharmaceuticals Limited's last earnings report?
  • When does Telix Pharmaceuticals Limited report earnings?

What is the ticker symbol for Telix Pharmaceuticals Limited?

The ticker symbol for Telix Pharmaceuticals Limited is NASDAQ:TLX

Does Telix Pharmaceuticals Limited pay dividends?

No, Telix Pharmaceuticals Limited does not pay dividends

What sector is Telix Pharmaceuticals Limited in?

Telix Pharmaceuticals Limited is in the Healthcare sector

What industry is Telix Pharmaceuticals Limited in?

Telix Pharmaceuticals Limited is in the Biotechnology industry

What country is Telix Pharmaceuticals Limited based in?

Telix Pharmaceuticals Limited is headquartered in Australia

When did Telix Pharmaceuticals Limited go public?

Telix Pharmaceuticals Limited's initial public offering (IPO) was on November 14, 2024

Is Telix Pharmaceuticals Limited in the S&P 500?

No, Telix Pharmaceuticals Limited is not included in the S&P 500 index

Is Telix Pharmaceuticals Limited in the NASDAQ 100?

No, Telix Pharmaceuticals Limited is not included in the NASDAQ 100 index

Is Telix Pharmaceuticals Limited in the Dow Jones?

No, Telix Pharmaceuticals Limited is not included in the Dow Jones index

When was Telix Pharmaceuticals Limited's last earnings report?

Telix Pharmaceuticals Limited's most recent earnings report was on Aug 22, 2024

When does Telix Pharmaceuticals Limited report earnings?

The next expected earnings date for Telix Pharmaceuticals Limited is Feb 21, 2025